49 research outputs found
Tuning the bioactivity of tensioactive deoxy glycosides to structure: antibacterial activity versus selective cholinesterase inhibition rationalized by molecular docking
New octyl/dodecyl 2,6-dideoxy-D-arabino-hexopyranosides
have been synthesized by a simple but efficient methodology
based on the reaction of glycals with alcohols catalysed by
triphenylphosphane hydrobromide, deprotection, regioselective tosylation and reduction. Their surface-active properties
were evaluated in terms of adsorption and aggregation parameters and compared with those of 2-deoxy-D-glycosides
and 2,6-dideoxy-L-glycosides. Deoxygenation at the 6-position led to a decrease in the critical micelle concentration,
and an increase in the adsorption efficiency (pC20) promoting
aggregation more efficiently than adsorption. With regard to
the antibacterial activity, dodecyl 2,6-dideoxy-α-L-arabino-hexopyranoside was the most active compound towards Bacillus anthracis (MIC 25 μM), whereas its enantiomer exhibited a MIC value of 50 μM. Both 2,6-dideoxy glycosides were
active towards Bacillus cereus, Bacillus subtilis, Enterococcus
faecalis and Listeria monocytogenes. In contrast, none of the
2-deoxy glycosides was significantly active. These results
and the data on surface activity suggest that aggregation is
a key issue for antimicrobial activity. Beyond infection, Alzheimer’s disease also threatens elderly populations. In the search for butyrylcholinesterase (BChE) selective inhibition, 2-
deoxy glycosides were screened in vitro by using Ellman’s
assay. Octyl 2-deoxy-α-D-glycoside was found to be a BChE
selective inhibitor promoting competitive inhibition. Docking
studies supported these results as they pinpoint the importance of the primary OH group in stabilizing the BChE inhibitor complex. A size-exclusion mechanism for inhibition has
been proposed based on the fact that acetylcholinesterase
(AChE) exhibits several bulky residues that hinder access to
the active-site cavity. This work shows how the deoxygenation pattern, configuration and functionality of the anomeric
centre can tune physical and surface properties as well as
the bioactivity of these multifunctional and stereochemically
rich molecules.FEDER e FCTinfo:eu-repo/semantics/publishedVersio
Recommended from our members
The E3 ubiquitin ligase SCF(Fbxo7) mediates proteasomal degradation of UXT isoform 2 (UXT-V2) to inhibit the NF-κB signaling pathway.
BACKGROUND: Ubiquitously eXpressed Transcript isoform 2 (UXTV2) is a prefoldin-like protein involved in NF-κB signaling, apoptosis, and the androgen and estrogen response. UXT-V2 is a cofactor in the NF-κB transcriptional enhanceosome, and its knockdown inhibits TNF-α -induced NF-κB activation. Fbxo7 is an F-box protein that interacts with SKP1, Cullin1 and RBX1 proteins to form an SCF(Fbxo7) E3 ubiquitin ligase complex. Fbxo7 negatively regulates NF-κB signaling through TRAF2 and cIAP1 ubiquitination. METHODS: We combine co-immunoprecipitation, ubiquitination in vitro and in vivo, cycloheximide chase assay, ubiquitin chain restriction analysis and microscopy to investigate interaction between Fbxo7 and overexpressed UXT-V2-HA. RESULTS: The Ubl domain of Fbxo7 contributes to interaction with UXTV2. This substrate is polyubiquitinated by SCF(Fbxo7) with K48 and K63 ubiquitin chain linkages in vitro and in vivo. This post-translational modification decreases UXT-V2 stability and promotes its proteasomal degradation. We further show that UXTV1, an alternatively spliced isoform of UXT, containing 12 additional amino acids at the N-terminus as compared to UXTV2, also interacts with and is ubiquitinated by Fbxo7. Moreover, FBXO7 knockdown promotes UXT-V2 accumulation, and the overexpression of Fbxo7-ΔF-box protects UXT-V2 from proteasomal degradation and enhances the responsiveness of NF-κB reporter. We find that UXT-V2 colocalizes with Fbxo7 in the cell nucleus. CONCLUSIONS: Together, our study reveals that SCF(Fbxo7) mediates the proteasomal degradation of UXT-V2 causing the inhibition of the NF-κB signaling pathway. GENERAL SIGNIFICANCE: Discovering new substrates of E3 ubiquitin-ligase SCF(Fbxo7) contributes to understand its function in different diseases such as cancer and Parkinson.Biotechnology and Biological Science Research Council [BB/J007846/1]
Lower production of IL-17A and increased susceptibility to Mycobacterium bovis in mice coinfected with Strongyloides venezuelensis
The presence of intestinal helminths can down-regulate the immune response required to control mycobacterial infection. BALB/c mice infected with Mycobacterium bovis following an infection with the intestinal helminth Strongyloides venezuelensis showed reduced interleukin-17A production by lung cells and increased bacterial burden. Also, small granulomas and a high accumulation of cells expressing the inhibitory molecule CTLA-4 were observed in the lung. These data suggest that intestinal helminth infection could have a detrimental effect on the control of tuberculosis (TB) and render coinfected individuals more susceptible to the development of TB
Platelet-Activating Factor Receptor Plays a Role in Lung Injury and Death Caused by Influenza A in Mice
Influenza A virus causes annual epidemics which affect millions of people
worldwide. A recent Influenza pandemic brought new awareness over the health
impact of the disease. It is thought that a severe inflammatory response against
the virus contributes to disease severity and death. Therefore, modulating the
effects of inflammatory mediators may represent a new therapy against Influenza
infection. Platelet activating factor (PAF) receptor (PAFR) deficient mice were
used to evaluate the role of the gene in a model of experimental infection with
Influenza A/WSN/33 H1N1 or a reassortant Influenza A H3N1 subtype. The following
parameters were evaluated: lethality, cell recruitment to the airways, lung
pathology, viral titers and cytokine levels in lungs. The PAFR antagonist
PCA4248 was also used after the onset of flu symptoms. Absence or antagonism of
PAFR caused significant protection against flu-associated lethality and lung
injury. Protection was correlated with decreased neutrophil recruitment, lung
edema, vascular permeability and injury. There was no increase of viral load and
greater recruitment of NK1.1+ cells. Antibody responses were
similar in WT and PAFR-deficient mice and animals were protected from
re-infection. Influenza infection induces the enzyme that synthesizes PAF,
lyso-PAF acetyltransferase, an effect linked to activation of TLR7/8. Therefore,
it is suggested that PAFR is a disease-associated gene and plays an important
role in driving neutrophil influx and lung damage after infection of mice with
two subtypes of Influenza A. Further studies should investigate whether
targeting PAFR may be useful to reduce lung pathology associated with Influenza
A virus infection in humans
Concentração de propriedade e desempenho: um estudo nas empresas brasileiras de capital aberto do setor de energia elétrica
Technical and economic viability of co-inoculation with Azospirillum brasilense in soybean cultivars in the Cerrado
Catolicismo e ciências sociais no Brasil: mudanças de foco e perspectiva num objeto de estudo
Rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART): Study protocol for a randomized controlled trial
Background: Acute respiratory distress syndrome (ARDS) is associated with high in-hospital mortality. Alveolar recruitment followed by ventilation at optimal titrated PEEP may reduce ventilator-induced lung injury and improve oxygenation in patients with ARDS, but the effects on mortality and other clinical outcomes remain unknown. This article reports the rationale, study design, and analysis plan of the Alveolar Recruitment for ARDS Trial (ART). Methods/Design: ART is a pragmatic, multicenter, randomized (concealed), controlled trial, which aims to determine if maximum stepwise alveolar recruitment associated with PEEP titration is able to increase 28-day survival in patients with ARDS compared to conventional treatment (ARDSNet strategy). We will enroll adult patients with ARDS of less than 72 h duration. The intervention group will receive an alveolar recruitment maneuver, with stepwise increases of PEEP achieving 45 cmH(2)O and peak pressure of 60 cmH2O, followed by ventilation with optimal PEEP titrated according to the static compliance of the respiratory system. In the control group, mechanical ventilation will follow a conventional protocol (ARDSNet). In both groups, we will use controlled volume mode with low tidal volumes (4 to 6 mL/kg of predicted body weight) and targeting plateau pressure <= 30 cmH2O. The primary outcome is 28-day survival, and the secondary outcomes are: length of ICU stay; length of hospital stay; pneumothorax requiring chest tube during first 7 days; barotrauma during first 7 days; mechanical ventilation-free days from days 1 to 28; ICU, in-hospital, and 6-month survival. ART is an event-guided trial planned to last until 520 events (deaths within 28 days) are observed. These events allow detection of a hazard ratio of 0.75, with 90% power and two-tailed type I error of 5%. All analysis will follow the intention-to-treat principle. Discussion: If the ART strategy with maximum recruitment and PEEP titration improves 28-day survival, this will represent a notable advance to the care of ARDS patients. Conversely, if the ART strategy is similar or inferior to the current evidence-based strategy (ARDSNet), this should also change current practice as many institutions routinely employ recruitment maneuvers and set PEEP levels according to some titration method.Hospital do Coracao (HCor) as part of the Program 'Hospitais de Excelencia a Servico do SUS (PROADI-SUS)'Brazilian Ministry of Healt